Long-Term Mortality of Tuberculosis Survivors in Korea: A Population-based Longitudinal Study

Abstract Background When assessing long-term tuberculosis (TB) mortality, few studies addressed the impact of behavior habits and socioeconomic status. Therefore, we aimed to evaluate long-term TB mortality and risk factors while accounting for potential confounders. Methods This cohort study included TB survivors (n = 82 098) aged ≥20 years between 2010 and 2017, and 1:1 age- and sex-matched controls (n = 82 098). The participants were followed up for death 1 year after study enrollment until December 2018. Long-term mortality was adjusted for behavior habits (smoking, alcohol consumption, or exercise), income level, body mass index (BMI), and comorbidities. Results During a median of 3.7 years of follow-up, the incidence rate of mortality was significantly higher in TB survivors than those in the matched controls (18.2 vs. 8.8 per 1000 person-years, P < .001). Even after adjusting for potential confounders, the mortality risk was 1.62-fold (95% confidence interval [CI], 1.54–1.70) higher in TB survivors than those in the matched controls. In addition, the hazard of mortality in TB survivors relative to matched controls significantly increased in participants aged ≥30 years, with the highest risk in those in their 40s. Male sex (adjusted hazard ratio [HR]: 2.31; 95% CI, 2.16–2.47), smoking pack-years (HR: 1.005; 95% CI, 1.004–1.006), heavy alcohol consumption (HR: 1.12; 95% CI, 1.01–1.23), and lowest income (HR: 1.27; 95% CI, 1.18–1.37) were positively associated with increased hazards for mortality, whereas higher BMI (HR: 0.91; 95% CI, .90–.92) and regular exercise (HR: 0.82; 95% CI, .76–.88) reduced the hazards of long-term mortality in TB survivors. Conclusions The long-term mortality risk was significantly higher in TB survivors than those in the matched controls, even after adjusting for potential confounders.

[1]  K. Han,et al.  Association between Smoking Status and Incident Non-Cystic Fibrosis Bronchiectasis in Young Adults: A Nationwide Population-Based Study , 2022, Journal of personalized medicine.

[2]  B. Cho,et al.  National General Health Screening Program in Korea: history, current status, and future direction: A scoping review , 2022, Precision and Future Medicine.

[3]  J. Sohn,et al.  Female reproductive factors and incidence of non-tuberculous mycobacterial pulmonary disease among postmenopausal women in Korea. , 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  S. Rhee,et al.  Body Mass Index, Diabetes, and Risk of Tuberculosis: A Retrospective Cohort Study , 2021, Frontiers in Nutrition.

[5]  Hojoong Kim,et al.  Pulmonary Tuberculosis and the Incidence of Lung Cancer among Patients with Chronic Obstructive Pulmonary Disease. , 2021, Annals of the American Thoracic Society.

[6]  N. Arinaminpathy,et al.  Economic impact of tuberculosis mortality in 120 countries and the cost of not achieving the Sustainable Development Goals tuberculosis targets: a full-income analysis , 2021, The Lancet Global Health.

[7]  Hayoung Choi Nosocomial exposure to tuberculosis: a snapshot of South Korea , 2021, The Korean journal of internal medicine.

[8]  S. Swaminathan,et al.  Long term Survival of Treated Tuberculosis patients in comparison to General Population in South India - a Matched Cohort study. , 2021, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[9]  Y. Park,et al.  Changes in Nutritional Status in Pulmonary Tuberculosis: Longitudinal Changes in BMI According to Acid-Fast Bacilli Smear Positivity , 2020, Journal of clinical medicine.

[10]  L. Bastos,et al.  Factors associated with death in patients with tuberculosis in Brazil: Competing risks analysis , 2020, PloS one.

[11]  Y. Kang,et al.  Long-term mortality of patients with tuberculosis in Korea. , 2020, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[12]  D. Visca,et al.  Rehabilitation, optimized nutritional care and boosting host internal milieu to improve long-term treatment outcomes in TB patients. , 2020, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[13]  H. Park,et al.  Impact of chronic obstructive pulmonary disease on mortality: A large national cohort study , 2020, Respirology.

[14]  C. Carvalho,et al.  Long-term survival and cause-specific mortality of patients newly diagnosed with tuberculosis in São Paulo state, Brazil, 2010–15: a population-based, longitudinal study , 2020, The Lancet. Infectious diseases.

[15]  J. Johnston,et al.  Long-term all-cause mortality in people treated for tuberculosis: a systematic review and meta-analysis. , 2019, The Lancet. Infectious diseases.

[16]  A. Welte,et al.  Morbidity and mortality up to 5 years post tuberculosis treatment in South Africa: A pilot study. , 2019, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[17]  V. H. Nguyen,et al.  Post-treatment Mortality Among Patients With Tuberculosis: A Prospective Cohort Study of 10 964 Patients in Vietnam , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  Y. Zheng,et al.  Tuberculosis-associated mortality and its risk factors in a district of Shanghai, China: a retrospective cohort study. , 2018, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[19]  R. Chaisson,et al.  Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  A. Leventhal,et al.  Mortality after anti-tuberculosis treatment completion: results of long-term follow-up. , 2016, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[21]  E. Guallar,et al.  Korean National Health Insurance Database. , 2016, JAMA internal medicine.

[22]  T. Sterling,et al.  Tuberculosis and cardiovascular disease: linking the epidemics , 2015, Tropical Diseases, Travel Medicine and Vaccines.

[23]  Fernando A. Wilson,et al.  Mortality hazard and survival after tuberculosis treatment. , 2015, American journal of public health.

[24]  F. Kok,et al.  Survival and associated mortality risk factors among post-treatment pulmonary tubercolosis patients in the northwest of China. , 2015, European review for medical and pharmacological sciences.

[25]  Å. Andersen,et al.  Long-term mortality in patients with pulmonary and extrapulmonary tuberculosis: a Danish nationwide cohort study , 2014, Clinical epidemiology.

[26]  S. Jang,et al.  The association between airflow obstruction and radiologic change by tuberculosis. , 2014, Journal of thoracic disease.

[27]  F. Sung,et al.  Tuberculosis increases the subsequent risk of acute coronary syndrome: a nationwide population-based cohort study. , 2014, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[28]  M. Rahu,et al.  Overall and cause-specific mortality among patients with tuberculosis and multidrug-resistant tuberculosis. , 2013, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[29]  J. Yim,et al.  Use of inhaled corticosteroids and the risk of tuberculosis , 2013, Thorax.

[30]  Z. Memish,et al.  Tuberculosis comorbidity with communicable and non-communicable diseases: integrating health services and control efforts. , 2013, The Lancet. Infectious diseases.

[31]  M. Petticrew,et al.  The social determinants of tuberculosis: from evidence to action. , 2011, American journal of public health.

[32]  S. Anton,et al.  How Much Walking Is Needed To Improve Cardiorespiratory Fitness? An Examination of the 2008 Physical Activity Guidelines for Americans , 2011, Research quarterly for exercise and sport.

[33]  A. Bernabé-Ortiz,et al.  Weight Variation over Time and Its Association with Tuberculosis Treatment Outcome: A Longitudinal Analysis , 2011, PloS one.

[34]  C. Dye,et al.  A consistent log-linear relationship between tuberculosis incidence and body mass index. , 2010, International journal of epidemiology.

[35]  R. Perera,et al.  Adaptation and validation of the Charlson Index for Read/OXMIS coded databases , 2010, BMC family practice.

[36]  Jiachun Lu,et al.  COPD in Chinese nonsmokers , 2009, European Respiratory Journal.

[37]  P. R. Narayanan,et al.  Excess mortality and risk factors for mortality among a cohort of TB patients from rural south India. , 2008, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[38]  G. Valdivia,et al.  Tuberculosis and airflow obstruction: evidence from the PLATINO study in Latin America , 2007, European Respiratory Journal.

[39]  R. Adegbola,et al.  Investigation of the risk factors for tuberculosis: a case-control study in three countries in West Africa. , 2005, International journal of epidemiology.

[40]  N. Beeching,et al.  Elevated mortality following diagnosis with a treatable disease: tuberculosis. , 2005, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[41]  C. Nishida,et al.  Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies , 2004, The Lancet.